Sagility India IPO

Sagility India IPO: Adani, 360 ONE, and Others Invest Over ₹360 Crore Ahead of Public Offering

Sagility India, a prominent tech-enabled healthcare services provider, is set to launch its IPO on November 5, 2024, and will remain open until November 7, 2024. The IPO has attracted major investors, with the pre-IPO phase raising over ₹360 crore from investors including 360 ONE, Avendus Future Leaders Fund II, and Adani Properties. The IPO is structured as an Offer-for-Sale (OFS) with no fresh issue component, targeting a capital raise of ₹2,106.60 crore, and offering shares at a price band of ₹28-₹30 per share. The IPO includes a reserve allocation for different investor categories, with 75% for qualified institutional buyers (QIBs), 15% for non-institutional investors (NIIs), and 10% for retail investors.

Investment Highlights

• Pre-IPO Investment: Sagility India attracted investments totaling over ₹360 crore ahead of the IPO. Key participants include:
  • 360 ONE – Acquired a 1.07% stake for ₹150 crore.
  • Avendus Future Leaders Fund II – Secured 0.9% for ₹126 crore.
  • Adani Properties – Owned by Gautam Adani’s family, bought a 0.14% stake for ₹20 crore.
  • Other investors include Jasub Property Holdings, Elpro International, PAM Family Trust, and prominent individuals like Jaya Chandrakant Gogri and Rashesh Chandrakant Gogri.
• Financial Performance: For FY 2023-24, Sagility India’s revenue increased by 12.7% to ₹4,753.56 crore, while profit after tax rose by 50% to ₹228.27 crore. In Q1 FY 2024-25, the company reported revenue of ₹1,223.33 crore and a net profit of ₹22.29 crore.
• Company Profile: Sagility India provides healthcare services, primarily to U.S.-based payers (insurance firms) and providers (hospitals, physicians). This positions Sagility as a significant player in the healthcare services sector with a focus on technology-driven solutions.

Advantages of Investing in Sagility India IPO

1. Established Healthcare Services Player: Sagility India’s experience in the U.S. healthcare sector, especially in tech-enabled services, provides a robust business foundation and growth potential.
2. Strong Financial Performance: The company has shown consistent growth, with a revenue increase of 12.7% and a 50% jump in net profits in FY 2023-24, indicating a positive financial trajectory.
3. Broad Institutional Investor Base: Sagility has garnered substantial investment interest from notable institutional investors, enhancing credibility and signaling a positive outlook for IPO performance.
4. Sector Demand and Growth Potential: The U.S. healthcare sector has a growing need for streamlined and technology-driven services, positioning Sagility to leverage its expertise and expand further.
5. High Retail Affordability: With a lot size set at 500 shares at ₹28-₹30 each, retail investors can access the IPO with an initial investment as low as ₹14,000.

Disadvantages of Investing in Sagility India IPO

1. Highly Competitive Market: The healthcare services sector is competitive, especially with major global players. Sagility India must continue innovating to maintain its edge.
2. Dependence on U.S. Healthcare Market: With a significant share of business tied to the U.S. healthcare market, any adverse regulatory changes or economic downturns could impact the company’s profitability.
3. Lack of Fresh Capital Infusion: Since the IPO is an Offer-for-Sale, the proceeds will not directly fund the company’s growth or expansion but will instead benefit existing shareholders.
4. Short-Term Volatility Post-IPO: Given the rapid price fluctuations common in new IPOs, especially with high-profile investors involved, initial market volatility might impact short-term returns.
5. Economic and Regulatory Risks: The company is exposed to regulatory changes in both India and the U.S., which could pose risks, particularly in sectors like healthcare.

Conclusion

Sagility India’s IPO offers investors an opportunity to invest in a well-positioned healthcare services provider with a strong growth record and robust investor backing. While the company shows promise due to its financial performance and investor interest, potential investors should consider the competitive landscape, the implications of Sagility’s dependency on the U.S. healthcare sector, and the absence of fresh capital from this IPO.

FAQs

1. What is the price band for the Sagility India IPO?
   • The IPO price band is set between ₹28 and ₹30 per share.
2. When will the Sagility India IPO open and close?
   • The IPO opens for subscription on November 5, 2024, and closes on November 7, 2024.
3. What is the minimum investment required?
   • Investors need to bid for at least 500 shares, totaling a minimum investment of ₹14,000 at the lower end of the price band.
4. Will the IPO proceeds be used for the company’s growth?
   • No, this IPO is an Offer-for-Sale, meaning the proceeds will go to the selling shareholders rather than to the company for growth or expansion.
5. Who are some of the major pre-IPO investors?
   • Major investors include 360 ONE, Avendus Future Leaders Fund II, and Adani Properties, among others.

Sagility India IPO

Gensol Engineering Secures ₹780 Crore Solar PV Project, Shares Surge Nearly 5%